10x Genomics (TXG) Other Non Operating Income (2018 - 2026)

10x Genomics has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$3.9 million for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 249.33% year-over-year to -$3.9 million; the TTM figure through Jun 2026 stood at -$8.4 million (down 323.22% YoY), while the FY2025 annual figure was $1.0 million, up 149.83% from the prior year.
• Other Non Operating Income came in at -$3.9 million for Q2 2026 at 10x Genomics, down from -$815000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $4.0 million in Q4 2022 to a low of -$3.9 million in Q2 2026.
• Average Other Non Operating Income over 5 years is -$345722.2, with a median of -$1.1 million recorded in 2024.
• The largest YoY upside for Other Non Operating Income was 79800.0% in 2022 against a maximum downside of 453.74% in 2022.
• Over 5 years, Other Non Operating Income stood at $4.0 million in 2022, then declined by 0.33% to $4.0 million in 2023, then sank by 176.57% to -$3.0 million in 2024, then increased by 16.56% to -$2.5 million in 2025, then tumbled by 52.79% to -$3.9 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$3.9 million in Q2 2026, -$815000.0 in Q1 2026, and -$2.5 million in Q4 2025.